Physician profile
Pooja Sethi
NPI 1639458987
$9,864.21
in general payments reported to CMS, 2019-2025
15 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,799 · 2020: $295 · 2021: $275 · 2022: $1,608 · 2023: $5,424 · 2024: $339 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,565 · Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,565.00 |
| Food and Beverage | $1,321.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $4,884.88 | 2019-2024 | |
| Heartflow, INC. | $2,847.95 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $520.79 | 2019-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $373.44 | 2023-2024 | |
| Pfizer INC. | $247.65 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $154.98 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $140.61 | 2023-2024 | Camzyos |
| Cvrx, INC. | $130.88 | 2023 | Barostim Neo System |
| Ars Pharmaceuticals Operations, INC. | $124.06 | 2025 | Neffy |
| Janssen Pharmaceuticals, INC | $109.65 | 2021-2023 | Xarelto |
| Akcea Therapeutics, INC. | $107.01 | 2020 | |
| Alnylam Pharmaceuticals INC. | $96.63 | 2019 | |
| Novo Nordisk INC | $75.99 | 2023 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $29.09 | 2019 | |
| Philips North America LLC | $20.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.